Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
allergies
Pharma
ARS hits major setback in bid to launch epinephrine newcomer
The company had already aligned with the FDA in August on final labeling and a post-marketing study plan. Now, it's appealing the FDA rejection.
Fraiser Kansteiner
Sep 20, 2023 10:31am
MVP Cooper Kupp joins Pataday allergy eye drop team
Jun 10, 2022 8:03am
Claritin campaign taps celebrity designers Berkus and Brent
May 4, 2022 8:00am
Orexo unveils nasal EpiPen rival, sets sights on 2022 trial
Dec 7, 2021 10:05am
Stallergenes taps Aptar for connected drug delivery project
Nov 1, 2021 12:22pm
FDA clears Ocular's Dextenza for eye itching from allergies
Oct 12, 2021 10:20am
